Literature DB >> 9971776

Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking.

A Mangasarian1, V Piguet, J K Wang, Y L Chen, D Trono.   

Abstract

The Nef protein of primate lentiviruses triggers the accelerated endocytosis of CD4 and of class I major histocompatibility complex (MHC-I), thereby down-modulating the cell surface expression of these receptors. Nef acts as a connector between the CD4 cytoplasmic tail and intracellular sorting pathways both in the Golgi and at the plasma membrane, triggering the de novo formation of CD4-specific clathrin-coated pits (CCP). The downstream partners of Nef in this event are the adapter protein complex (AP) of CCP and possibly a subunit of the vacuolar ATPase. Whether Nef-induced MHC-I down-regulation stems from a similar mechanism is unknown. By comparing human immunodeficiency virus type 1 (HIV-1) Nef mutants for their ability to affect either CD4 or MHC-I expression, both in transient-transfection assays and in the context of HIV-1 infection, it was determined that Nef-induced CD4 and MHC-I down-regulation constitute genetically and functionally separate properties. Mutations affecting only CD4 regulation mapped to residues previously shown to mediate the binding of Nef to this receptor, such as W57 and L58, as well as to an AP-recruiting dileucine motif and to an acidic dipeptide in the C-terminal region of the protein. In contrast, mutation of residues in an alpha-helical region in the proximal portion of Nef and amino acid substitutions in a proline-based SH3 domain-binding motif selectively affected MHC-I down-modulation. Although both the N-terminal alpha-helix and the proline-rich region of Nef have been implicated in recruiting Src family protein kinases, the inhibitor herbimycin A did not block MHC-I down-regulation, suggesting that the latter process is not mediated through an activation of this family of tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971776      PMCID: PMC104438     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.

Authors:  Y Uehara; H Fukazawa
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

Authors:  C H June; M C Fletcher; J A Ledbetter; G L Schieven; J N Siegel; A F Phillips; L E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.

Authors:  J V Garcia; A D Miller
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

5.  Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1.

Authors:  T Seshamma; O Bagasra; D Trono; D Baltimore; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

6.  Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells.

Authors:  J Kaminchik; N Bashan; A Itach; N Sarver; M Gorecki; A Panet
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells.

Authors:  A Pelchen-Matthews; J E Armes; M Marsh
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

8.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

Authors:  K Umesono; K K Murakami; C C Thompson; R M Evans
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

9.  Specificity of binding of clathrin adaptors to signals on the mannose-6-phosphate/insulin-like growth factor II receptor.

Authors:  J N Glickman; E Conibear; B M Pearse
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

10.  Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells.

Authors:  A Pelchen-Matthews; J E Armes; G Griffiths; M Marsh
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  98 in total

1.  HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes.

Authors:  V Piguet; L Wan; C Borel; A Mangasarian; N Demaurex; G Thomas; D Trono
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

2.  Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions.

Authors:  L X Liu; N Heveker; O T Fackler; S Arold; S Le Gall; K Janvier; B M Peterlin; C Dumas; O Schwartz; S Benichou; R Benarous
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation.

Authors:  H Akari; S Arold; T Fukumori; T Okazaki; K Strebel; A Adachi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 4.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  HIV-1 Nef impairs MHC class II antigen presentation and surface expression.

Authors:  P Stumptner-Cuvelette; S Morchoisne; M Dugast; S Le Gall; G Raposo; O Schwartz; P Benaroch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

6.  Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation.

Authors:  S Le Gall; F Buseyne; A Trocha; B D Walker; J M Heard; O Schwartz
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 7.  The MHC class I antigen presentation pathway: strategies for viral immune evasion.

Authors:  Eric W Hewitt
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 8.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 9.  Virus subversion of protective immunity.

Authors:  Eric W Hewitt; Gillian E Dugan
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

10.  HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity.

Authors:  Jakob E Larsen; Ramiro H Massol; Thomas J F Nieland; Tomas Kirchhausen
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.